New York Oncology Hematology PC - Amsterdam is a clinical research site located in Amsterdam, New York, United States 12010.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
New York Oncology Hematology PC - Amsterdam has participated in 12 clinical trials with 4 currently active.
Therapeutic areas: Extensive Stage Small Cell Lung Carcinoma, Recurrent Small Cell Lung Carcinoma, Recurrent Uterine Corpus Carcinoma.
Sponsors: National Cancer Institute (NCI), GOG Foundation, NSABP Foundation Inc.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
New York Oncology Hematology PC - Amsterdam has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York Oncology Hematology PC - Amsterdam has 12 clinical trials on record, with 4 currently active. Their work covers Extensive Stage Small Cell Lung Carcinoma, Recurrent Small Cell Lung Carcinoma, Recurrent Uterine Corpus Carcinoma.
Yes — New York Oncology Hematology PC - Amsterdam holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.